BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gèze A, Chau LT, Choisnard L, Mathieu J, Marti-batlle D, Riou L, Putaux J, Wouessidjewe D. Biodistribution of intravenously administered amphiphilic β-cyclodextrin nanospheres. International Journal of Pharmaceutics 2007;344:135-42. [DOI: 10.1016/j.ijpharm.2007.06.050] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Zhang H, An W, Liu Z, Hao A, Hao J, Shen J, Zhao X, Sun H, Sun L. Redox-responsive vesicles prepared from supramolecular cyclodextrin amphiphiles. Carbohydrate Research 2010;345:87-96. [DOI: 10.1016/j.carres.2009.10.022] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
2 Perret P, Bacot S, Gèze A, Gentil Dit Maurin A, Debiossat M, Soubies A, Blanc-marquis V, Choisnard L, Boutonnat J, Ghezzi C, Putaux J, Lancelon-pin C, Riou L, Wouessidjewe D. Biodistribution and preliminary toxicity studies of nanoparticles made of Biotransesterified β–cyclodextrins and PEGylated phospholipids. Materials Science and Engineering: C 2018;85:7-17. [DOI: 10.1016/j.msec.2017.12.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
3 Gèze A, Choisnard L, Putaux J, Wouessidjewe D. Colloidal systems made of biotransesterified α, β and γ cyclodextrins grafted with C10 alkyl chains. Materials Science and Engineering: C 2009;29:458-62. [DOI: 10.1016/j.msec.2008.08.027] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
4 Sheng Y, Liu C, Yuan Y, Tao X, Yang F, Shan X, Zhou H, Xu F. Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan. Biomaterials 2009;30:2340-8. [PMID: 19150737 DOI: 10.1016/j.biomaterials.2008.12.070] [Cited by in Crossref: 163] [Cited by in F6Publishing: 153] [Article Influence: 13.6] [Reference Citation Analysis]
5 Yaméogo JB, Gèze A, Choisnard L, Putaux J, Gansané A, Sirima SB, Semdé R, Wouessidjewe D. Self-assembled biotransesterified cyclodextrins as Artemisinin nanocarriers – I: Formulation, lyoavailability and in vitro antimalarial activity assessment. European Journal of Pharmaceutics and Biopharmaceutics 2012;80:508-17. [DOI: 10.1016/j.ejpb.2011.12.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
6 Bonnet V, Gervaise C, Djedaïni-Pilard F, Furlan A, Sarazin C. Cyclodextrin nanoassemblies: a promising tool for drug delivery. Drug Discov Today 2015;20:1120-6. [PMID: 26037681 DOI: 10.1016/j.drudis.2015.05.008] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 10.0] [Reference Citation Analysis]
7 Quaglia F, Ostacolo L, Mazzaglia A, Villari V, Zaccaria D, Sciortino MT. The intracellular effects of non-ionic amphiphilic cyclodextrin nanoparticles in the delivery of anticancer drugs. Biomaterials 2009;30:374-82. [DOI: 10.1016/j.biomaterials.2008.09.035] [Cited by in Crossref: 106] [Cited by in F6Publishing: 95] [Article Influence: 8.8] [Reference Citation Analysis]
8 Gharibzahedi SM, Jafari SM. Nanocapsule formation by cyclodextrins. Nanoencapsulation Technologies for the Food and Nutraceutical Industries. Elsevier; 2017. pp. 187-261. [DOI: 10.1016/b978-0-12-809436-5.00007-0] [Cited by in Crossref: 7] [Article Influence: 1.8] [Reference Citation Analysis]
9 Kompella UB, Amrite AC, Pacha Ravi R, Durazo SA. Nanomedicines for back of the eye drug delivery, gene delivery, and imaging. Prog Retin Eye Res 2013;36:172-98. [PMID: 23603534 DOI: 10.1016/j.preteyeres.2013.04.001] [Cited by in Crossref: 144] [Cited by in F6Publishing: 128] [Article Influence: 18.0] [Reference Citation Analysis]
10 Zeng J, Huang H, Liu S, Xu H, Huang J, Yu J. Hollow nanosphere fabricated from β-cyclodextrin-grafted α,β-poly(aspartic acid) as the carrier of camptothecin. Colloids Surf B Biointerfaces 2013;105:120-7. [PMID: 23376743 DOI: 10.1016/j.colsurfb.2012.12.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
11 Xie G, Wang C, Sun J, Zhong G. Tissue distribution and excretion of intravenously administered titanium dioxide nanoparticles. Toxicol Lett 2011;205:55-61. [PMID: 21600967 DOI: 10.1016/j.toxlet.2011.04.034] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 7.2] [Reference Citation Analysis]
12 Yaméogo JB, Gèze A, Choisnard L, Putaux J, Mazet R, Passirani C, Keramidas M, Coll J, Lautram N, Bejaud J, Semdé R, Wouessidjewe D. Self-assembled biotransesterified cyclodextrins as potential Artemisinin nanocarriers. II: In vitro behavior toward the immune system and in vivo biodistribution assessment of unloaded nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 2014;88:683-94. [DOI: 10.1016/j.ejpb.2014.08.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
13 Kim J, Seo T, Lim S. Preparation of aqueous dispersion of β-carotene nano-composites through complex formation with starch dextrin. Food Hydrocolloids 2013;33:256-63. [DOI: 10.1016/j.foodhyd.2013.04.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
14 Zerkoune L, Angelova A, Lesieur S. Nano-Assemblies of Modified Cyclodextrins and Their Complexes with Guest Molecules: Incorporation in Nanostructured Membranes and Amphiphile Nanoarchitectonics Design. Nanomaterials (Basel) 2014;4:741-65. [PMID: 28344245 DOI: 10.3390/nano4030741] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 8.9] [Reference Citation Analysis]
15 Lakkakula JR, Maçedo Krause RW. A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications. Nanomedicine (Lond) 2014;9:877-94. [PMID: 24981652 DOI: 10.2217/nnm.14.41] [Cited by in Crossref: 87] [Cited by in F6Publishing: 68] [Article Influence: 14.5] [Reference Citation Analysis]
16 Bilensoy E, Hincal AA. Recent advances and future directions in amphiphilic cyclodextrin nanoparticles. Expert Opinion on Drug Delivery 2009;6:1161-73. [DOI: 10.1517/17425240903222218] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 7.2] [Reference Citation Analysis]
17 Chen L, Lin Y, Zhang Z, Yang R, Bai X, Liu Z, Luo Z, Zhou M, Zhong Z. A novel dual-prodrug carried by cyclodextrin inclusion complex for the targeting treatment of colon cancer. J Nanobiotechnology 2021;19:329. [PMID: 34666761 DOI: 10.1186/s12951-021-01064-3] [Reference Citation Analysis]
18 Arima H, Motoyama K, Irie T. Recent Findings on Safety Profiles of Cyclodextrins, Cyclodextrin Conjugates, and Polypseudorotaxanes. In: Bilensoy E, editor. Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine. Hoboken: John Wiley & Sons, Inc.; 2011. pp. 91-122. [DOI: 10.1002/9780470926819.ch5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
19 Ozcan I, Segura-Sánchez F, Bouchemal K, Sezak M, Ozer O, Güneri T, Ponchel G. Pegylation of poly(γ-benzyl-L-glutamate) nanoparticles is efficient for avoiding mononuclear phagocyte system capture in rats. Int J Nanomedicine 2010;5:1103-11. [PMID: 21270961 DOI: 10.2147/IJN.S15493] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
20 Yu W, Liu C, Ye J, Zou W, Zhang N, Xu W. Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery. Nanotechnology 2009;20:215102. [DOI: 10.1088/0957-4484/20/21/215102] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]